AMCP Submits Comments on PDUFA; AMCP Joins Influenza Antiviral Sign-on Letter; AMCP Joins COVID-19 Antiviral Recommendations Sign-on Letter; President Biden Signs Infrastructure Investment and Jobs Act; President Biden To Nominate Dr. Robert Califf for FDA Commissioner.
AMCP Celebrates Grassroots Advocates at Nexus 2021; Congress Passes Continuing Resolution to Avoid Government Shutdown; Raises Debt Ceiling to Avert Default; FDA and CDC Approve Pfizer Booster; CMS Releases 2022 Premiums and Cost-Sharing Information for Medicare Advantage & Part D Plans; CMS Releases MA, Part D Star Ratings for 2022; MACPAC Report on Medicaid Churn.
Join us for a Grassroots Reception at Nexus 2021; Expanding Access to COVID-19 Therapeutics –HHS PREP Act Declaration: Ninth Amendment; HHS Comprehensive Plan for Addressing High Drug Prices; AMCP Virtual Legislative Days 2021; ICYMI: Respond to AMCP Policy Action Items Survey; AMCP Urges Congress to Implement Continuous Eligibility for Children in Medicaid and CHIP.
AMCP Urges HHS to Extend Medicare Part D Enhanced MTM Mode; Biden Administration Withdraws the Most Favored Nations Model; AMCP Supports FDA Approval of Biosimilar Insulin; President Biden Calls on Congress to Reduce Drug Prices.
AMCP Submits Comments on OMB Equity RFI; President Biden Signs Executive Order on Increasing Competition; CMS Opens National Coverage Determination Process for Aduhelm; Congress Releases 21st Century Cures 2.0 Discussion Draft.
AMCP-Legislative-Regulatory-Briefing-June-2021; AMCP Submits Comments on Proposed Part D MTM Program CMR Changes; Medicaid Drug Rebate Program Best Price Rule Delayed; 2021 Federal and State Legislative and Regulatory Update Available on AMCP Learn; AMCP Statement of Support for CMS Administrator Brooks-LaSure.
January 2022 News & Views: AMCP Strategic Priorities Quarterly Update; Attend the Premier Managed Care Event of the Year; Highlighting the Value of Managed Care Tools; AMCP Publishes New Pay-for-Performance Principles; Check Out the Best of Nexus 2021 on AMCP Learn.